Prognostic importance of anaemia in patients with acute pulmonary embolism

Thrombosis and Haemostasis

Volumn 106, Issue 2, 2011, Pages 289-295

  Donzé, Jacques ^a   Labarère, José ^a   Méan, Marie ^b   Jiménez, David ^c   Aujesky, Drahomir ^d  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b LABORATOIRE TIMC IMAG   (France)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

Lung; Risk factors; Thrombosis

Indexed keywords

HEMOGLOBIN;

ACUTE DISEASE; ADULT; AGE; AGED; ANEMIA; ARTICLE; CONTROLLED STUDY; FEMALE; GENDER; HEALTH INSURANCE; HOSPITAL DISCHARGE; HUMAN; LENGTH OF STAY; LOGISTIC REGRESSION ANALYSIS; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RACE; UNITED STATES;

ACUTE DISEASE; AGED; ANEMIA; FEMALE; HEMOGLOBINS; HUMANS; LENGTH OF STAY; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PENNSYLVANIA; PROGNOSIS; PULMONARY EMBOLISM;

EID: 79961045656     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH11-04-0208     Document Type: Article

References (26)

1. Sabatine MS, Morrow DA, Giugliano RP, et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 2005; 111: 2042-2049.
2. Groenveld HF, Januzzi JL, Damman K, et al. Anemia and mortality in heart failure patients a systematic review and meta-analysis. J Am Coll Cardiol 2008; 52: 818-827.
3. Waterer GW, Kessler LA, Wunderink RG. Medium-term survival after hospitalization with community-acquired pneumonia. Am J Respir Crit Care Med 2004; 169: 910-914.
4. Chambellan A, Chailleux E, Similowski T. Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy. Chest 2005; 128: 1201-1208.
5. Cote C, Zilberberg MD, Mody SH, et al. Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur Respir J 2007; 29: 923-929.
6. Young JB, Abraham WT, Albert NM, et al. Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry). Am J Cardiol 2008; 101: 223-230.
7. Kosiborod M, Curtis JP, Wang Y, et al. Anemia and outcomes in patients with heart failure: a study from the National Heart Care Project. Arch Intern Med 2005; 165: 2237-2244.
8. Nordyke RJ, Kim JJ, Goldberg GA, et al. Impact of anemia on hospitalization time, charges, and mortality in patients with heart failure. Value Health 2004; 7: 464-471.
9. DeFrances CJ, Cullen KA, Kozak LJ. National Hospital Discharge Survey: 2005 annual summary with detailed diagnosis and procedure data. National Center for Health Statistics. Vital Health Stat 2007; 13: 1-209.
10. Aujesky D, Obrosky DS, Stone RA, et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med 2005; 172: 1041-1046.
11. Jimenez D, Escobar C, Marti D, et al. Association of anaemia and mortality in patients with acute pulmonary embolism. Thromb Haemost 2009; 102: 153-158.
12. Aujesky D, Roy PM, Le Manach CP, et al. Validation of a model to predict adverse outcomes in patients with pulmonary embolism. Eur Heart J 2006; 27: 476-481.
13. Donzé J, Grégoire Le Gal G, Fine MJ, et al. rospective validation of the Pulmonary Embolism Severity Index: A clinical prognostic model for pulmonary embolism. Thromb Haemost 2008; 100: 943-948.
14. Beutler E, Waalen J. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood 2006; 107: 1747-1750.
15. Anker SD, Voors A, Okonko D, et al. Prevalence, incidence, and prognostic value of anaemia in patients after an acute myocardial infarction: data from the OPTIMAAL trial. Eur Heart J 2009; 30: 1331-1339.
16. Komajda M, Anker SD, Charlesworth A, et al. The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET. Eur Heart J 2006; 27: 1440-1446.
17. MacMahon B. The National Death Index. Am J Public Health 1983; 73: 1247-1248.
18. Williams BC, Demitrack LB, Fries BE. The accuracy of the National Death Index when personal identifiers other than Social Security number are used. Am J Public Health 1992; 82: 1145-1147.
19. Cowper DC, Kubal JD, Maynard C, et al. A primer and comparative review of major US mortality databases. Ann Epidemiol 2002; 12: 462-468.
20. Ibrahim SA, Stone RA, Obrosky DS, et al. Thrombolytic therapy and mortality in patients with acute pulmonary embolism. Arch Intern Med 2008; 168: 2181-2190.
21. Torbicki A, Perrier A, Konstantinides S, et al. Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008; 29: 2276-2315.
22. Ruiz-Gimenez N, Suarez C, Gonzalez R, et al. Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry. Thromb Haemost 2008; 100: 26-31.
23. Anand IS, Chandrashekhar Y, Ferrari R, et al. Pathogenesis of oedema in chronic severe anaemia: studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones. Br Heart J 1993; 70: 357-362.
24. White RH, Garcia M, Sadeghi B, et al. Evaluation of the predictive value of ICD-9-CM coded administrative data for venous thromboembolism in the United States. Thromb Res 2010; 126: 61-67.
25. Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: 454S-545S.
26. Sam A, Sanchez D, Gomez V, et al. Usefulness of the shock index and the simplified pulmonary embolism severity index for identification of low-risk patientes with acute pulmonary embolism. Eur Respir J 2011; 37: 762-766.